Filing Flows › Repligen (RGEN) › Q2 2026 › vs Q2 2025
Repligen (RGEN) Q2 2026 vs Q2 2025 (year over year)
Repligen's revenue rose $21.8M (+12%) from $182M in Q2 2025 to $204M in Q2 2026. The biggest changes: Product +$21.8M (+12%); Royalty +$6K (+16%). Operating margin 6.8% against 7.6% (-0.8 pts).
Repligen, Q2 2026: revenue $204M (+12% year over year), operating margin 6.8%, net earnings $5.0M, operating cash flow $32.8M. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Operating margin | 6.8% | 7.6% | -0.8 pts |
| Net margin | 2.5% | 8.2% | -5.7 pts |
| Free cash flow margin | 13.4% | 11.8% | +1.6 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Product | $204M | $182M | $21.8M | +12% |
| Royalty | $43K | $37K | $6K | +16% |
| Revenue | $204M | $182M | $21.8M | +12% |
| Operating profit | $14.0M | $13.9M | $80K | +0.6% |
| Costs & expenses | $190M | $168M | $21.7M | +13% |
| Pre-tax earnings | $14.2M | $18.2M | −$4.1M | -22% |
| Net earnings | $5.0M | $14.9M | −$9.9M | -66% |
| Income tax | $9.1M | $3.3M | $5.8M | +173% |
| Depreciation & amortization | $19.1M | $20.1M | −$1.0M | -5% |
| Share-based compensation | $8.0M | $8.4M | −$362K | -4% |
| Working capital & other | $683K | −$14.7M | $15.4M | — |
| Operating cash flow | $32.8M | $28.6M | $4.2M | +15% |
| Free cash flow (OCF − capex) | $27.4M | $21.5M | $5.9M | +28% |
| Capital expenditures | $5.3M | $7.1M | −$1.8M | -25% |
Questions
How much did Repligen's revenue grow year over year in Q2 2026?
Repligen's revenue rose $21.8M (+12%) from $182M in Q2 2025 to $204M in Q2 2026.
What drove Repligen's revenue change in Q2 2026?
Product +$21.8M (+12%); Royalty +$6K (+16%).